Pierrel Logo

Pierrel

Pharmaceutical firm specializing in dental anesthetics and contract manufacturing.

PRL | XMIL

Overview

Corporate Details

ISIN(s):
IT0005549644
LEI:
8156002BC7CB6E3BD403
Country:
Italy
Address:
STRADA STATALE APPIA 7 BIS, 46/48, 81043 CAPUA

Description

Pierrel is a global pharmaceutical company specializing in oral health. With over 70 years of experience, the company focuses on the development, production, registration, and licensing of dental anesthetics and complementary medical devices. Its core expertise lies in the aseptic manufacturing of injectable drugs. The product portfolio includes a wide range of dental anesthetics marketed under its own brands, such as Orabloc®, Ubisestin™, Xylestesin™, and Mepivastesin™. In addition to its branded products, Pierrel offers medical devices for oral pathology screening, prevention, and regeneration. The company also provides contract manufacturing services to the pharmaceutical and life science industries. Its production facilities are authorized by major global regulatory agencies, including the EMA and FDA, ensuring compliance with high international quality standards.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2016-06-29 22:30
Pierrel S.p.A.: VERSAMENTI IN CONTO FUTURO AUMENTO DI CAPITALE EFFETTUATI DAGLI…
Italian 129.2 KB
2016-06-28 07:01
Pierrel S.p.A.: ORABLOC® IN USA: AL SECONDO POSTO NEL COMPARTO DELL’ARTICAINA. …
Italian 137.2 KB
2016-06-17 15:08
Pierrel S.p.A.: VARIAZIONE CAPITALE SOCIALE. DEPOSITO DELLO STATUTO SOCIALE AGG…
Italian 136.9 KB
2016-06-17 14:46
Pierrel S.p.A.: Verbale Assemblea Azionisti del 30/05/2016
Italian 164.9 KB
2016-06-17 14:41
Pierrel: Statuto
Italian 126.2 KB
2016-06-17 07:01
Pierrel S.p.A.: SOTTOSCRITTO UN ACCORDO DECENNALE CON SAFCO DENTAL SUPPLY CO.
Italian 129.9 KB
2016-06-16 11:02
Pierrel S.p.A.: COMUNICAZIONE SULLO STATO MEMBRO D’ORIGINE
English 123.0 KB
2016-05-31 22:17
Pierrel S.p.A.: Informativa mensile ai sensi dell’art. 114, comma 5, D.Lgs. N. …
Italian 224.9 KB
2016-05-30 22:05
Pierrel S.p.A.:RIUNITA L’ASSEMBLEA DEGLI AZIONISTI IN SEDE ORDINARIA E STRAORDI…
Italian 254.9 KB
2016-05-27 07:01
Pierrel S.p.A.: VERSAMENTO IN CONTO FUTURO AUMENTO DI CAPITALE DA PARTE DELL’AZ…
Italian 124.9 KB
2016-05-26 07:01
Pierrel S.p.A.: INFORMAZIONI IN MERITO A THERAMETRICS HOLDING AG
Italian 149.3 KB
2016-05-23 07:01
Pierrel S.p.A.: SMILE, UBIGEL e INIETTORI MONOUSO PIERREL
Italian 242.5 KB
2016-05-13 21:51
Pierrel S.p.A.: IL CDA APPROVA SU BASE VOLONTARIA IL RESOCONTO INTERMEDIO DI GE…
Italian 705.8 KB
2016-05-13 21:48
Pierrel S.p.A.: Resoconto Intermedio di Gestione al 31 Marzo 2016
Italian 829.6 KB
2016-05-06 18:35
Pierrel S.p.A.: Pubblicazione di documenti per l’Assemblea degli azionisti conv…
Italian 135.8 KB

Automate Your Workflow. Get a real-time feed of all Pierrel filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pierrel

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pierrel via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Celltrion, Inc. Logo
Biopharmaceutical firm developing biosimilars for autoimmune diseases and oncology.
South Korea
068270
Celltrion Pharm Inc. Logo
Manufactures and supplies chemical pharmaceuticals and biosimilar products.
South Korea
068760
Develops and manufactures medical devices, tissue grafts, and advanced biologics.
South Korea
049180
Celon Pharma S.A. Logo
An integrated pharmaceutical company researching and manufacturing modern drugs.
Poland
CLN
Celularity Inc Logo
Develops allogeneic cell therapies and biomaterials from the human placenta.
United States of America
CELU
Centessa Pharmaceuticals plc Logo
Clinical-stage pharmaceutical company developing medicines for unmet medical needs.
United States of America
CNTA
Century Therapeutics, Inc. Logo
Develops iPSC-derived allogeneic cell therapies for cancer and autoimmune diseases.
United States of America
IPSC
Cereno Scientific AB Logo
Clinical-stage biotech developing drugs for rare cardiovascular & pulmonary diseases.
Sweden
CRNO
CERO THERAPEUTICS HOLDINGS, INC. Logo
Immunotherapy company developing engineered T cell therapeutics for cancer treatment.
United States of America
CERO
CERUS CORP Logo
Develops pathogen inactivation technology to reduce transfusion-transmitted infections.
United States of America
CERS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.